课题基金 / 基金详情

CCR7 expression in T cell subsets in children with allergic diseases

CCR7 expression in T cell subsets in children with allergic diseases
过敏性疾病儿童T细胞亚群中CCR7的表达
批准号:
13670786
负责人:
ADACHI Yuichi
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

ADACHI Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
众所周知,与成人相比,婴儿和幼儿表现出较低的产生免疫应答的能力,导致对感染性和过敏性疾病的易感性增加。趋化因子受体之一的CCR 7已被描述为两种不同类型的记忆T细胞(称为中枢记忆T细胞和效应记忆T细胞)的定义因子。因此,我们评估了健康和过敏儿童CCR 7表达的发育变化。虽然随着年龄的增长,CD 4+和CD 8 + T细胞上的CCR 7表达动态变化,但在健康和过敏受试者之间没有显著差异。然后,我们评估了IL-12产生的发育变化,IL-12在Th 1细胞的发育中具有重要作用。单核细胞产生IL-12的能力在出生时可以忽略不计,并随着年龄的增长而逐渐增加。在超过7岁时,过敏受试者的IL-12产生显著低于健康受试者。意外的发现是,食物过敏的婴儿具有更高的IL-12产生能力。这些结果表明,许多免疫因素随着年龄的增长而发展,其中一些与变态反应性疾病有关。在临床情况下,监测这些标志物可能有助于评估过敏性疾病的Th 1/Th 2平衡。
英文摘要
It is well known that infants and young children show a lower capability to mount immune responses as compared with adults, resulting in an increasing susceptibility to infectious and allergic diseases, CCR7, one of chemokine receptors, has been described as a defining factor for two different types of memory T cells, termed central and effector memory T cells. Therefore, we evaluated developmental changes in CCR7 expression of healthy and allergic children. Although CCR7 expression on CD4+ and CD8+ T cells changed dynamically as aging, there was no significant difference between healthy and allergic subjects. Then we evaluated developmental changes in production of IL-12, which has an important role in developing Th1 cells. The ability of monocytes to produce IL-12 was negligible at birth and gradually, increased with advancing age. At more than 7 years of age, IL-12 production of allergic subjects was significantly lower compared with healthy subjects. The unexpected finding was that infants with food allergy had higher ability of IL-12 production. These results suggest that many immunological factors developed as aging, and that some of them are related with allergic diseases. In clinical situation, monitoring these markers could be useful to evaluate Th1/Th2 balance in allergic diseases.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
T Itazawa: "Developmental changes in IL-12 producing ability by monocytes and their relevance to allergic diseases"Clin Exp Allergy.
T Itazawa:“单核细胞产生 IL-12 能力的发展变化及其与过敏性疾病的相关性”Clin Exp Allergy。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T. Itazawa, et al.: "Developmental changes in interleukin-12-producing ability by monocytes and their relevance to allergic diseases."Clin Exp Allergy. 33. 525-530 (2003)
T. Itazawa 等人:“单核细胞产生白细胞介素 12 的能力的发育变化及其与过敏性疾病的相关性。”Clin Exp Allergy。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T Itazawa: "Developmental changes in IL-12 producing ability by monocytes and their relevance to allergic diseases"Clin Exp Allergy. (in press). (2003)
T Itazawa:“单核细胞产生 IL-12 能力的发展变化及其与过敏性疾病的相关性”Clin Exp Allergy。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
CD30 expression in CD4+T cell subsets in children with atopic diseases
国内基金
海外基金
KCTD10对2型免疫反应(Th2)的调控研究
  • 批准号:
    2020JJ4441
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    任凯群
  • 依托单位:
IL-6受体泛素化调控机制
  • 批准号:
    32070775
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    李姝
  • 依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
  • 批准号:
    31970735
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    江静
  • 依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
  • 批准号:
    31900556
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2019
  • 负责人:
    林恒
  • 依托单位: